We believe in direct communication, honest dialogue, and collaborative working. Confidentiality is absolutely assured in every aspect of our service, from your first enquiry onwards.

Our in-house scientific expertise enables us to approach every project from the most fundamental principles, thoroughly researching your drug and building a complete understanding of its mechanism and potential efficacy, and then providing a dosage design that will deliver the best possible results.

We understand the importance of costs and timelines, and make sure that these factors are clearly set out and agreed at the outset.

While our aim is to meet your immediate requirements, we always look ahead to ensure that the short-run manufacturing we do can easily be scaled to commercial quantities or licensed to another party.

Our working practice is to agree a fee for each stage of our service, in advance. We will not tie you in to formulations or technologies that will reduce your future options. Our work, once paid for, is yours without further commitment.

The Quay Pharma Process, Stage by Stage:

1: We carry out a collaborative research and analysis project, to investigate the parameters and scope of the project and explore the contribution we can make. All of the work, even at this initial stage before you incur any costs, is absolutely confidential.

2: We prepare a proposal setting out the scope of the work we propose to do, the milestones we will meet along the way, the deliverable outcomes, the costs and the schedules. At this stage, we will make it clear where the various responsibilities lie, and whether we need any further information or assurances from you.

3: We sign a technical agreement with you, defining the work we will do and the setting out deliverables, milestones, timelines, schedules and costs. This is the first stage at which you make any commitment to us.

4: We manage the project according to the agreement, and at each milestone we report back to you, review the work we’ve done and agree on the next stage.

QuayPharma -Modified Release Tablet Formulations

Details